PDGFRA and neoplasm: This cooperation with p53 and the RAS/MAPK pathway is supported by the frequent co-occurrence of PDGFRA and TP53 alterations with H3K27M in human DIPGs, although in human tumours H3K27M is clearly the initiating event21,22.